Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Ridgeback Biotherapeutics
Pharma
Merck's Lagevrio may have triggered new COVID variants: study
As coronavirus concerns increase with the changing of the seasons, the most commonly used oral antiviral treatments are in the spotlight once again.
Kevin Dunleavy
Sep 26, 2023 9:35am
Slump of Merck's COVID-19 pill continues with trial failure
Feb 21, 2023 10:53am
Emergent to produce Ebola drug Ebanga in U.S. for Ridgeback
Jul 8, 2022 10:22am
Paxlovid usage is ticking up in the US
May 26, 2022 10:40am
ICER's latest cost analysis favors Paxlovid over molnupiravir
May 10, 2022 8:55am
Pfizer's Paxlovid to be on tap for thousands more in the U.K.
Apr 12, 2022 10:12am
